Skip to Main Content

Paper Details

<i>APOL1</i> Kidney Risk Variants and Cardiovascular Disease: An Individual Participant Data Meta-Analysis.
J Am Soc Nephrol
21
2019
APOL1, APOL1 genotype, APOL1 kidney-risk variants, Cardiovascular Disease, Kidney Risk Variants, Kidney disease, Participant, apo L1 gene, cardiovascular disease, coronary heart disease, diabetes, heart failure, kidney disease, myocardial infarction, participant, participants, stroke
Author NameAffiliation
Morgan E GramsJohns Hopkins University School of Medicine
Morgan E GramsWelch Center for Prevention, and Clinical Research, Johns Hopkins Medical Institutions
Morgan E GramsJohns Hopkins University Bloomberg School of Public Health
Eric BoerwinkleThe University of Texas Health Science Center at Houston
Eric BoerwinkleThe University of Texas Health Science Center at Houston
Josef CoreshWelch Center for Prevention, and Clinical Research, Johns Hopkins Medical Institutions
Josef CoreshJohns Hopkins University Bloomberg School of Public Health
Jasmin Divers
Jasmin Divers
Marguerite R Irvin
Marguerite R IrvinUniversity of Alabama at Birmingham
Joachim H IxUniversity of California
Joachim H IxVeterans Affairs San Diego Healthcare System
Jeffrey B KoppNational Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health
Carl D Langefeld
Carl D Langefeld
Kenneth J MukamalBeth Israel Deaconess Medical Center
Solomon K Musani
Carmen A PeraltaUniversity of California san francisco
Carmen A Peralta
Carmen A PeraltaSan Francisco Veterans Affairs Medical Center
Adrienne TinWelch Center for Prevention, and Clinical Research, Johns Hopkins Medical Institutions
Adrienne TinJohns Hopkins University Bloomberg School of Public Health
Christina L WasselInc.
Christina L WasselInc.
James G WilsonUniversity of Mississippi Medical Center
James G WilsonUniversity of Mississippi Medical Center
Barry I FreedmanWake Forest School of Medicine
  • 1 - 28

Datasets

Release 1.2